MENU
EYPT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

EyePoint (EYPT) Ownership - Who owns EyePoint?

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care... Show more

Profile

Industry
Pharmaceuticals Major
Address
480 Pleasant Street
Phone
+1 833 393-7646
Employees
214
Web
https://www.eyepoint.bio

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.07M
P/E Ratio
-0.11
Total Cash
180.47M
Projected Growth
0.38
Total Debt
19.81M
Revenue
2.79M
Risk (Beta)
2.17
Dividend Yield
N/A
Total Cash/Share
2.09
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Who owns EyePoint? EYPT symbol Ownership - Tickeron.com